| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2671 | 2021 |
| Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ... Nature medicine 9 (6), 729-735, 2003 | 713 | 2003 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 508 | 2016 |
| A review of malaria vaccine clinical projects based on the WHO rainbow table L Schwartz, GV Brown, B Genton, VS Moorthy Malaria journal 11, 1-22, 2012 | 371 | 2012 |
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, ... The Lancet Infectious Diseases 15 (10), 1156-1166, 2015 | 319 | 2015 |
| Experimental human challenge infections can accelerate clinical malaria vaccine development RW Sauerwein, M Roestenberg, VS Moorthy Nature Reviews Immunology 11 (1), 57-64, 2011 | 305 | 2011 |
| Malaria vaccine developments VS Moorthy, MF Good, AVS Hill The lancet 363 (9403), 150-156, 2004 | 286 | 2004 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 247 | 2022 |
| Data sharing for novel coronavirus (COVID-19) V Moorthy, AMH Restrepo, MP Preziosi, S Swaminathan Bulletin of the World Health Organization 98 (3), 150, 2020 | 237 | 2020 |
| Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open … MD Tapia, SO Sow, KE Lyke, FC Haidara, F Diallo, M Doumbia, A Traore, ... The Lancet infectious diseases 16 (1), 31-42, 2016 | 236 | 2016 |
| WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23–24 March 2015 K Modjarrad, B Giersing, DC Kaslow, PG Smith, VS Moorthy, ... Vaccine 34 (2), 190-197, 2016 | 216 | 2016 |
| A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults VS Moorthy, EB Imoukhuede, P Milligan, K Bojang, S Keating, P Kaye, ... PLoS medicine 1 (2), e33, 2004 | 216 | 2004 |
| Status of vaccine research and development of vaccines for Staphylococcus aureus BK Giersing, SS Dastgheyb, K Modjarrad, V Moorthy Vaccine 34 (26), 2962-2966, 2016 | 183 | 2016 |
| Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study O De Santis, R Audran, E Pothin, L Warpelin-Decrausaz, L Vallotton, ... The Lancet infectious diseases 16 (3), 311-320, 2016 | 172 | 2016 |
| Ebola vaccine—an urgent international priority R Kanapathipillai, AM Henao Restrepo, P Fast, D Wood, C Dye, MP Kieny, ... New England Journal of Medicine 371 (24), 2249-2251, 2014 | 160 | 2014 |
| Immunological mechanisms underlying protection mediated by RTS, S: a review of the available data VS Moorthy, WR Ballou Malaria journal 8, 1-7, 2009 | 159 | 2009 |
| Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against … SM Keating, P Bejon, T Berthoud, JM Vuola, S Todryk, DP Webster, ... The Journal of Immunology 175 (9), 5675-5680, 2005 | 158 | 2005 |
| Developing global norms for sharing data and results during public health emergencies K Modjarrad, VS Moorthy, P Millett, PS Gsell, C Roth, MP Kieny PLoS Medicine 13 (1), e1001935, 2016 | 157 | 2016 |
| Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis SC Gilbert, VS Moorthy, L Andrews, AA Pathan, SJ McConkey, JM Vuola, ... Vaccine 24 (21), 4554-4561, 2006 | 148 | 2006 |
| Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results VS Moorthy, G Karam, KS Vannice, MP Kieny PLoS medicine 12 (4), e1001819, 2015 | 146 | 2015 |
